Literature DB >> 6889697

Serial two-dimensional echocardiography in Duchenne muscular dystrophy.

S J Goldberg, L Z Stern, L Feldman, H D Allen, D J Sahn, L M Valdes-Cruz.   

Abstract

Patients with Duchenne muscular dystrophy (DMD) are known to have progressive epicardial fibrosis of the free wall of the left ventricle, but standard noninvasive M-mode echocardiographic tests of left ventricular function are relatively insensitive detectors of this cardiomyopathy. We therefore used two-dimensional echocardiography to record three short axis levels of the left ventricle in 13 Duchenne patients. Serial studies were separated by 2 years for most patients. The two-dimensional echocardiographic technique allows qualitative evaluation of segmental contraction of the left ventricle. Four general principles were found during this study: (1) Obvious contraction abnormalities of the left ventricle were present in most patients with DMD. (2) In most patients, the contraction deficit was first noted in the left ventricular posterior free wall behind the mitral valve. (3) Once a contraction deficit was observed, the area of abnormal contraction progressed inferiorly to include additional areas of the left ventricular posterior free wall. (4) Standard M-mode left ventricular function techniques were unreliable for detecting individuals with segmental contraction abnormalities.

Entities:  

Mesh:

Year:  1982        PMID: 6889697     DOI: 10.1212/wnl.32.10.1101

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.

Authors:  Abhinandan Batra; Alison M Barnard; Donovan J Lott; Rebecca J Willcocks; Sean C Forbes; Saptarshi Chakraborty; Michael J Daniels; Jannik Arbogast; William Triplett; Erik K Henricson; Jonathan G Dayan; Carsten Schmalfuss; Lee Sweeney; Barry J Byrne; Craig M McDonald; Krista Vandenborne; Glenn A Walter
Journal:  BMC Cardiovasc Disord       Date:  2022-06-09       Impact factor: 2.174

2.  The Use of Speckle Tracking Echocardiography for Early Detection of Myocardial Dysfunction in Patients with Duchenne Muscular Dystrophy.

Authors:  Anas Taqatqa; John Bokowski; Maytham Al-Kubaisi; Ahmad Khalil; Carlos Miranda; Hamad Alaksham; Ibtihaj Fughhi; Damien Kenny; Karim A Diab
Journal:  Pediatr Cardiol       Date:  2016-07-25       Impact factor: 1.655

3.  Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?

Authors:  Michael D Puchalski; Richard V Williams; Bojana Askovich; C Todd Sower; Kan H Hor; Jason T Su; Nathan Pack; Edward Dibella; William M Gottliebson
Journal:  Int J Cardiovasc Imaging       Date:  2008-08-07       Impact factor: 2.357

4.  Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.

Authors:  K Folkers; J Wolaniuk; R Simonsen; M Morishita; S Vadhanavikit
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

5.  Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study.

Authors:  Kan N Hor; Janaka Wansapura; Larry W Markham; Wojciech Mazur; Linda H Cripe; Robert Fleck; D Woodrow Benson; William M Gottliebson
Journal:  J Am Coll Cardiol       Date:  2009-04-07       Impact factor: 24.094

6.  Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy.

Authors:  Shaji C Menon; Susan P Etheridge; Kirk N Liesemer; Richard V Williams; Tyler Bardsley; Mason C Heywood; Michael D Puchalski
Journal:  Pediatr Cardiol       Date:  2014-05-15       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.